Banga JD - Search Results

1

Lipid-lowering therapy in diabetes mellitus.

Niemeijer-Kanters SD, Banga JD, Erkelens DW. Niemeijer-Kanters SD, et al. Among authors: banga jd. Neth J Med. 2001 May;58(5):214-22. doi: 10.1016/s0300-2977(01)00105-x. Neth J Med. 2001. PMID: 11414234 Review.

2

Clinical relevance of the methionine loading test for assessment of hyperhomocysteinaemia.

van der Griend R, Biesma DH, Banga JD. van der Griend R, et al. Among authors: banga jd. Neth J Med. 2000 Oct;57(4):174-5. doi: 10.1016/s0300-2977(00)00057-7. Neth J Med. 2000. PMID: 11185483 No abstract available.

3

Thyrotoxicosis, protein C deficiency and lupus anticoagulant in a case of cerebral sinus thrombosis.

De Schryver EL, Hoogenraad TU, Banga JD, Kappelle LJ. De Schryver EL, et al. Among authors: banga jd. Neth J Med. 1999 Oct;55(4):201-2. doi: 10.1016/s0300-2977(99)00065-0. Neth J Med. 1999. PMID: 10555439 No abstract available.

4

Hyperhomocysteinaemia as a cardiovascular risk factor: an update.

van der Griend R, Biesma DH, Banga JD. van der Griend R, et al. Among authors: banga jd. Neth J Med. 2000 Mar;56(3):119-30. doi: 10.1016/s0300-2977(99)00132-1. Neth J Med. 2000. PMID: 10759023 Review.

5

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.

Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP. Kappelle PJ, et al. Among authors: banga jd. Expert Opin Ther Targets. 2009 Jul;13(7):743-51. doi: 10.1517/14728220903023866. Expert Opin Ther Targets. 2009. PMID: 19505224

6

Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus.

Niemeijer-Kanters SD, Dallinga-Thie GM, de Ruijter-Heijstek FC, Algra A, Erkelens DW, Banga JD, Jansen H. Niemeijer-Kanters SD, et al. Among authors: banga jd. Atherosclerosis. 2001 May;156(1):209-16. doi: 10.1016/s0021-9150(00)00642-0. Atherosclerosis. 2001. PMID: 11369016

7

Coagulation and fibrinolysis in diabetes.

Banga JD. Banga JD. Semin Vasc Med. 2002 Feb;2(1):75-86. doi: 10.1055/s-2002-23098. Semin Vasc Med. 2002. PMID: 16222598 Review.

8

Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

Teunissen LL, Franssen H, Wokke JH, van der Graaf Y, Linssen WH, Banga JD, Laman DM, Notermans NC. Teunissen LL, et al. Among authors: banga jd. J Neurol Neurosurg Psychiatry. 2002 May;72(5):590-5. doi: 10.1136/jnnp.72.5.590. J Neurol Neurosurg Psychiatry. 2002. PMID: 11971043 Free PMC article.

9

Intensive lipid-lowering strategy in patients with diabetes mellitus.

Kanters SD, Algra A, de Bruint TW, Erkelens DW, Banga JD. Kanters SD, et al. Among authors: banga jd. Diabet Med. 1999 Jun;16(6):500-8. doi: 10.1046/j.1464-5491.1999.00080.x. Diabet Med. 1999. PMID: 10391399 Clinical Trial.

10

Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.

Westerveld HT, de Graaf JC, van Breugel HH, Akkerman JW, Sixma JJ, Erkelens DW, Banga JD. Westerveld HT, et al. Among authors: banga jd. Diabetes Care. 1993 May;16(5):683-8. doi: 10.2337/diacare.16.5.683. Diabetes Care. 1993. PMID: 8495604 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results